
Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Privacy and HIPAA in telehealth ketamine therapy go hand in hand: before you share psychiatric history, trauma, substance use details, or a prescription for a Schedule III controlled substance with an online provider, you should know exactly how that information is protected. The Health Insurance Portability and Accountability Act (HIPAA) is the federal law that sets baseline privacy and security standards for how healthcare providers and their business associates handle protected health information in the United States. HIPAA compliance is not automatic just because a platform calls itself "telehealth." Understanding what the law actually requires, and what it does not cover, helps you evaluate a provider's privacy practices before you disclose anything about your mental health.
Quick Answer
Any licensed telehealth ketamine provider operating as a healthcare practice is a HIPAA covered entity, which means it must safeguard your health information, give you a Notice of Privacy Practices, and get your authorization before sharing your data outside of treatment, payment, or healthcare operations. The technology platform delivering your sessions must have a signed Business Associate Agreement (BAA) with the provider before it can legally process your protected health information. Because ketamine is a controlled substance and treats sensitive psychiatric conditions, ask directly about a provider's HIPAA status, BAA coverage, data storage location, and breach notification policy before you enroll.
HIPAA applies to "covered entities," which include healthcare providers, health plans, and healthcare clearinghouses, and to their "business associates," the vendors and partners who handle protected health information on the covered entity's behalf. Any licensed telehealth ketamine provider operating as a healthcare practice is a covered entity under HIPAA. That status requires the provider to:
- Implement administrative, physical, and technical safeguards to protect your health information
- Provide you with a Notice of Privacy Practices before treatment begins
- Obtain your authorization before sharing your information for purposes other than treatment, payment, or healthcare operations
- Give you access to your own medical records upon request
- Notify you if your data is breached
According to the U.S. Department of Health and Human Services, HIPAA's Breach Notification Rule requires covered entities to notify affected individuals within 60 days of discovering a breach of unsecured protected health information. If the telehealth platform is a separate technology company from the prescribing practice, it must execute a Business Associate Agreement (BAA), a contract that legally obligates the vendor to protect your data, with the provider. Without a signed BAA, the platform cannot legally process your protected health information.
Many telehealth platforms describe themselves as "HIPAA-compliant," but the term covers several distinct technical requirements. A telehealth ketamine platform that meets HIPAA's technical safeguards should have:
- Encrypted communications: video sessions, messages, and data transmissions encrypted in transit and at rest, using end-to-end encryption or TLS 1.2/1.3
- Secure data storage: patient records, session notes, symptom scores, and prescribing records held in access-controlled environments, often on HIPAA-compliant cloud infrastructure such as AWS GovCloud or Microsoft Azure for Healthcare
- Access controls: multi-factor authentication, role-based access, and audit logging that limits who can view your records
- BAAs with every vendor: not just between the platform and the provider, but with downstream vendors including pharmacy management systems, payment processors, scheduling software, and any email service that touches protected health information
Video Platform Red Flag
During the COVID-19 public health emergency, HHS temporarily allowed telehealth visits over non-HIPAA-compliant consumer video platforms such as FaceTime or standard Zoom. Those flexibilities have been scaled back. Reputable telehealth ketamine providers now use purpose-built telehealth systems or HIPAA-compliant video products, such as Zoom for Healthcare or Doxy.me, that have a signed BAA with the provider. If a provider tells you your sessions will happen over a standard consumer video platform without a BAA, treat that as a meaningful compliance red flag. Our guide to online ketamine clinic red flags covers other warning signs to watch for.
Ketamine is a Schedule III controlled substance, and mental health diagnoses carry particular stigma and legal weight. Your telehealth ketamine records may include psychiatric diagnoses such as depressionpost-traumatic stress disorder (PTSD), a mental health condition that can develop after experiencing or witnessing a traumatic event, or anxiety disorders, along with substance use history, symptom severity scores, psychedelic experience reports, and prescription records for a controlled substance.
Beyond standard HIPAA protections, some states have additional laws protecting mental health and substance use treatment records. 42 CFR Part 2 is a federal regulation, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), that provides enhanced privacy protections for records tied to substance use disorder treatment. Some providers take the position that ketamine therapy falls within its scope, particularly when treating substance use disorders, though this is not applied uniformly across the industry. You can review the SAMHSA 42 CFR Part 2 FAQ for the regulation's full scope.
Questions to Ask a Provider Before Enrolling
- Are you a HIPAA covered entity? If a provider is uncertain or evasive, that's a serious concern.
- Do you have a signed Business Associate Agreement (BAA) with your technology platform?
- Where is my data stored, and who has access to it?
- Do you share my data with third parties for marketing or research? This requires my explicit authorization under HIPAA.
- What is your data breach notification policy, and how quickly will I be told?
- How do I access or correct my medical records?
If your treatment is billed through insurance, your ketamine prescriptions and psychiatric diagnoses become part of your insurance record, which may be visible to future insurers or employers depending on jurisdiction. Many telehealth ketamine patients pay out of pocket specifically to keep this documentation out of insurance records. Compare the tradeoffs in our guide to insurance versus cash pay ketamine treatment.
A Prescription Drug Monitoring Program (PDMP) is a state-run database that tracks controlled substance prescriptions and is accessible to prescribers, pharmacists, and in some states, law enforcement. Every state maintains one, and your ketamine prescription will be reported to your state's PDMP. This is a legal requirement, not an optional disclosure, and it applies regardless of how privacy-conscious your telehealth provider is. Because controlled substance rules vary by state, review our telehealth legality overview before enrolling.
Some telehealth ketamine platforms integrate with separate wellness or mental health apps for symptom tracking or integration support. These apps may not themselves be HIPAA covered entities, so the protections that apply to your provider don't automatically extend to them. Read the separate privacy policy of any third-party app you're asked to use before sharing data through it.
Privacy Policy Checklist
- Clear language about what data is collected and why
- Explicit statements about HIPAA compliance and BAA execution
- A description of who your data is shared with and for what purpose
- Your rights to access, correct, and delete your information
- The company's data retention policy after treatment ends
- What happens to your data if the company is acquired or shuts down
Key Takeaway
A telehealth ketamine provider's privacy practices are a direct signal of how seriously it takes patient trust. Confirm HIPAA covered entity status, verify BAAs are in place with the platform and its vendors, and read the privacy policy in full before you share psychiatric history, substance use information, or details about a controlled substance prescription. See our guide on choosing a provider for a broader vetting framework.
Sources and further reading:
- StatPearls: Ketamine, a comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary, the National Center for Biotechnology Information's chemical database entry with ketamine's molecular data and pharmacokinetics
- MedlinePlus: Ketamine, National Library of Medicine consumer drug information including uses and precautions
- NIMH: Post-Traumatic Stress Disorder, the National Institute of Mental Health's overview of PTSD symptoms, risk factors, and treatment
- HHS: Telehealth, the U.S. Department of Health and Human Services guide to telehealth regulations and patient resources
Learn More
Compare vetted telehealth ketamine providers and see how their privacy, consent, and HIPAA practices measure up before you enroll.
Frequently Asked Questions
Share
Related Reading
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.


